New rapid PSA test could speed up prostate cancer detection

NCT ID NCT00853710

Completed Diagnosis Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a simple, rapid PSA blood test that gives results in minutes, comparing it to the standard lab PSA test. Researchers enrolled 94 men with prostate cancer or benign prostate disease. The goal was to see if the quick test is accurate enough for screening. If it works well, it could make prostate cancer screening more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rapid prostate specific antigen (PSA) assay
What this could lead to: If accurate, this rapid test could make prostate cancer screening faster and simpler, possibly in a doctor's office without sending blood to a lab.
What could go wrong: This is a small, completed validation study, not a treatment trial. The rapid test may not be as accurate as the standard lab test, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia neoplasm prostate cancer prostate disorder prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATIC DISEASES PROSTATIC NEOPLASMS

Contacts and locations

Locations

Centre Rene Huguenin

Saint-Cloud, 92210, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.